FORE Biotherapeutics vs OutSense Diagnostics

FORE Biotherapeutics vs OutSense Diagnostics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: FORE Biotherapeutics is on 56/100 and OutSense Diagnostics on 51/100.

FORE Biotherapeutics logo
FORE BiotherapeuticsPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
Try FORE Biotherapeutics
OutSense Diagnostics logo
OutSense DiagnosticsDevelops toilet-integrated diagnostic technology for early health condition detection.
Try OutSense Diagnostics

Where each one leads

FORE Biotherapeutics

  • our overall score: 56/100 against 51/100
  • agent readiness: 37/100 against 29/100
  • headcount: 56 against 23
  • funding raised: $232M against $2.7M
  • LinkedIn following: 4,584 against 1,343

OutSense Diagnostics

  • domain rating: 44/100 against 35/100

At a glance

MeasureFORE BiotherapeuticsOutSense Diagnostics
What it isPrecision oncology company developing cancer therapies guided by proprietary functional genomics.Develops toilet-integrated diagnostic technology for early health condition detection.
CategoryHealthcare, Drug Development, Genomics, Next Generation SequencingHealthcare, Personal, Toilet, Detection
Sells toBusiness modelB2BB2B, B2C
OfferingSoftwareHardware, Software
Founded20112016
HeadquartersPhiladelphia, United StatesTel Aviv, Israel
StatusActiveActive

Size, funding and growth

MeasureFORE BiotherapeuticsOutSense Diagnostics
Employees5623
Headcount growthLast 12 months+8.2%Not published
Total funding$232M$2.7M
Latest roundSeries D-2 ExtensionSeries A
Valuation$75.0MNot published
LinkedIn followers4,5841,343

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureFORE BiotherapeuticsOutSense Diagnostics
StartupHub scoreOur 0-100 rating56/10051/100
Traction58/10046/100
Team70/10060/100
Search visibility38/10030/100
Quality55/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (37/100)F (29/100)
Domain ratingLink authority, 0-10035/10044/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureFORE BiotherapeuticsOutSense Diagnostics
CDNNot detectedCloudflare
CMSWordPressNot detected
FrameworksJqueryNext.js, Tailwind CSS

FORE Biotherapeutics vs OutSense Diagnostics: common questions

Which is better, FORE Biotherapeutics or OutSense Diagnostics?

On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do FORE Biotherapeutics and OutSense Diagnostics compare on the numbers?

FORE Biotherapeutics leads on our overall score (56/100 against 51/100), agent readiness (37/100 against 29/100), headcount (56 against 23), funding raised ($232M against $2.7M), LinkedIn following (4,584 against 1,343). OutSense Diagnostics leads on domain rating (44/100 against 35/100).

Read the full FORE Biotherapeutics review and pricing or the OutSense Diagnostics review and pricing. You can also browse other FORE Biotherapeutics alternatives we track.